MedAvail Holdings (STU:73M) EBIT: €-38.26 Mil (TTM As of Jun. 2023)


STU:73M MedAvail Holdings Inc STU:73M
12 GF Score
Price €11.05
View Full Analysis

What is MedAvail Holdings EBIT?

MedAvail Holdings STU:73M 12 EBIT is €-38.26 Mil as of Jun. 2023. GuruFocus rates STU:73M with a GF Score™ of 12/100.

MedAvail Holdings's earnings before interest and taxes (EBIT) for the three months ended in Jun. 2023 was €-4.94 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2023 was €-38.26 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. MedAvail Holdings's annualized ROC % for the quarter that ended in Jun. 2023 was -128.09%. MedAvail Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -206.69%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

MedAvail Holdings  (STU:73M) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

MedAvail Holdings's annualized ROC % for the quarter that ended in Jun. 2023 is calculated as:

ROC % (Q: Jun. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2023 ) + Invested Capital (Q: Jun. 2023 ))/ count )
=-16.444 * ( 1 - 0% )/( (13.252 + 12.423)/ 2 )
=-16.444/12.8375
=-128.09 %

where

Invested Capital(Q: Mar. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=33.357 - 2.55 - ( 17.555 - max(0, 4.795 - 30.384+17.555))
=13.252

Invested Capital(Q: Jun. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=27.605 - 1.929 - ( 13.253 - max(0, 3.836 - 24.966+13.253))
=12.423

Note: The Operating Income data used here is four times the quarterly (Jun. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

MedAvail Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2023  Q: Jun. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-19.752/( ( (1.459 + max(8.262, 0)) + (1.323 + max(8.069, 0)) )/ 2 )
=-19.752/( ( 9.721 + 9.392 )/ 2 )
=-19.752/9.5565
=-206.69 %

where Working Capital is:

Working Capital(Q: Mar. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.193 + 8.127 + 4.509) - (2.55 + 0.257 + 1.76)
=8.262

Working Capital(Q: Jun. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.27 + 9.29 + 2.153) - (1.929 + 0.319 + 1.396)
=8.069

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

MedAvail Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2023 )
=-38.256/0.000
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedAvail Holdings EBIT Related Terms

MedAvail Holdings EBIT Historical Data

* Premium members only.

The historical data trend for MedAvail Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedAvail Holdings EBIT Chart

MedAvail Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22
EBIT
-18.72 -21.02 -38.25 -43.82

MedAvail Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.84 -11.61 -10.14 -11.57 -4.94

STU:73M vs HEWA, BIMI, MEDS: EBIT Comparison

For the Pharmaceutical Retailers subindustry, MedAvail Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MedAvail Holdings EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MedAvail Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where MedAvail Holdings's EV-to-EBIT falls into.


STU:73M
12GF Score
MedAvail Holdings Inc STU:73M
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MedAvail Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-38.26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €-38.26 Mil mean?
MedAvail Holdings (STU:73M) has a EBIT of €-38.26 Mil as of Jun. 2023. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on MedAvail Holdings.
Is MedAvail Holdings' EBIT too high?
MedAvail Holdings' current EBIT is €-38.26 Mil. Overall, MedAvail Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does MedAvail Holdings' EBIT compare to HEWA and BIMI?
MedAvail Holdings' EBIT of €-38.26 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on MedAvail Holdings. MedAvail Holdings's current EBIT is €-38.26 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedAvail Holdings stock overvalued right now?
MedAvail Holdings (STU:73M) has a current EBIT of €-38.26 Mil. The current EBIT is €-38.26 Mil. MedAvail Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For MedAvail Holdings (STU:73M), the current EBIT is €-38.26 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedAvail Holdings Business Description

Address 4720 East Cotton Gin Loop, Suite 220, Phoenix, AZ, USA, 85040
MedAvail Holdings Inc is a telehealth-enabled pharmacy technology company. It operates in two segments: Retail Pharmacy Services and Pharmacy Technology. It generates the majority of revenue from the Retail Pharmacy Services segment, which is into operating SpotRx, a full-service retail pharmacy utilizing MedAvail's automated pharmacy technology, servicing Medicare patients in the United States. The Pharmacy Technology segment develops and commercializes the MedCenter for direct sale or lease to third-party customers.
12GF Score

Get the complete analysis for STU:73M

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.05
Price